Write your message
Volume 9, Issue 4 (November 2022)                   IJML 2022, 9(4): 256-261 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sarkargar F, Madani Manshadi S A, Zare Mehrjardi E, Khodaei H, Kalantar S M, Mohammadi S A. A Compound Heterozygous HPD Mutation in an Iranian Patient with Hypertyrosinemia Type III. IJML 2022; 9 (4) :256-261
URL: http://ijml.ssu.ac.ir/article-1-445-en.html
Meybod Genetic Research Center, Meybod, Yazd, Iran
Abstract:   (763 Views)
Background and Aims: Hypertyrosinemia type 3 (HT3) is an inherited error in tyrosine metabolism caused by a mutation in the 4-hydroxyphenylpyruvate dioxygenase (HPD) gene. Here we report a one and half-year-old girl infant who was diagnosed based on increased serum tyrosine levels and increased urinary excretion of p-hydroxyphenyl derivatives.
Materials and Methods: The proband was one and half-year-old Iranian girl who was diagnosed based on increased serum tyrosine levels and increased urinary excretion of p-hydroxyphenyl derivatives. In this study, we used Whole-Exome Sequencing to identify the genetic reason for the disease and the funded mutation confirmed by Sanger sequencing.
Results and Conclusion: Through whole-exome sequencing screening of heterozygotes c.413C>T (p.T138M) and c.75G.A (p.W25Ter) in the HPD gene and genetically confirmed by Sanger sequencing. There were heterozygous conditions c.413C>T (p.T138M) and c.75G.A (p.W25Ter) in father and mother respectively. This mutation in her parents was also confirmed by Sanger sequencing.
Full-Text [PDF 364 kb]   (210 Downloads) |   |   Full-Text (HTML)  (291 Views)  
Type of Study: case report | Subject: Genetics/ Biotechnology
Received: 2022/04/9 | Accepted: 2022/12/13 | Published: 2022/12/31

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb